Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Sepracor Inc.
Sepracor Announces Senior Management Changes
March 12th, 2007
Sepracor Inc. (Nasdaq: SEPR) announced that Adrian Adams has been appointed President and Chief Operating Officer and W. James O'Shea has been appointed to the newly-created position of Vice Chairman of the Company. Mr. Adams was President and Chief Executive Officer of Kos Pharmaceuticals from 2002 until the acquisition of the company by Abbott Laboratories in December 2006 for $3.7 billion. During his tenure he increased revenues ten-fold and led the transformation of Kos into a fully integrated and profitable pharmaceutical company with annual revenues approaching one billion dollars and strong positions in the cardiovascular and respiratory disease areas. Mr. Adams...
Source: Pharma Business Week (2007-03-12)
|
